학술논문
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis
Document Type
Article
Author
Source
In: JAAD International . (JAAD International, March 2022, 6:27-36)
Subject
Language
English
ISSN
26663287